For research use only
| Cat No. | ABC-TC3944 |
| Product Type | Blood Products |
| Cell Type | Plasma |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Myelodysplastic Syndrome |
| Storage | Liquid Nitrogen |
Multiple Sclerosis (MS) peripheral blood plasma is obtained by centrifugation of the MS PB.
Human MS (Multiple Sclerosis) PB (Peripheral Blood) Plasma is an experimentally validated, cell-free biological matrix isolated from the peripheral blood (PB) of individuals diagnosed with multiple sclerosis (MS), containing plasma proteins, antibodies, and cytokines, with no associated cell types like lymphocytes or fibroblasts. Functionally, this plasma mediates immune responses and contains disease-relevant autoantibodies (e.g., against myelin components), with such autoantibodies representing key markers associated with MS pathogenesis. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human MS PB Plasma, Multiple Sclerosis Peripheral Plasma, MS Patient Plasma, MS Peripheral Blood Plasma |
| Species | Human |
| Cat.No | ABC-TC3944 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Plasma |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Myelodysplastic Syndrome |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Blood Products |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human MS (Multiple Sclerosis) PB (Peripheral Blood) Plasma can be used as an in vitro biological model to study the pathogenesis of multiple sclerosis (MS) and autoimmune neurological disorders. For example, by investigating its inflammatory cytokine profiles, autoantibody content, and effects on blood-brain barrier permeability or oligodendrocyte function when applied to neural cell cultures, researchers can explore molecular pathways underlying MS pathogenesis. This provides a better understanding of the humoral immune mechanisms and pathological mediators in MS, supporting discovery research and target identification for autoimmune central nervous system diseases and biomarker discovery for disease monitoring.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
